1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Antihemophilic Factor Drug Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Antihemophilic Factor Drug by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Antihemophilic Factor Drug by Country/Region, 2017, 2022 & 2028 2.2 Antihemophilic Factor Drug Segment by Type 2.2.1 250 IU 2.2.2 500 IU 2.2.3 1000 IU 2.2.4 1500 IU 2.2.5 2000 IU 2.2.6 3000 IU 2.2.7 4000 IU 2.2.8 Other potencies 2.3 Antihemophilic Factor Drug Sales by Type 2.3.1 Global Antihemophilic Factor Drug Sales Market Share by Type (2017-2022) 2.3.2 Global Antihemophilic Factor Drug Revenue and Market Share by Type (2017-2022) 2.3.3 Global Antihemophilic Factor Drug Sale Price by Type (2017-2022) 2.4 Antihemophilic Factor Drug Segment by Application 2.4.1 Adult 2.4.2 Pediatric 2.5 Antihemophilic Factor Drug Sales by Application 2.5.1 Global Antihemophilic Factor Drug Sale Market Share by Application (2017-2022) 2.5.2 Global Antihemophilic Factor Drug Revenue and Market Share by Application (2017-2022) 2.5.3 Global Antihemophilic Factor Drug Sale Price by Application (2017-2022) 3 Global Antihemophilic Factor Drug by Company 3.1 Global Antihemophilic Factor Drug Breakdown Data by Company 3.1.1 Global Antihemophilic Factor Drug Annual Sales by Company (2020-2022) 3.1.2 Global Antihemophilic Factor Drug Sales Market Share by Company (2020-2022) 3.2 Global Antihemophilic Factor Drug Annual Revenue by Company (2020-2022) 3.2.1 Global Antihemophilic Factor Drug Revenue by Company (2020-2022) 3.2.2 Global Antihemophilic Factor Drug Revenue Market Share by Company (2020-2022) 3.3 Global Antihemophilic Factor Drug Sale Price by Company 3.4 Key Manufacturers Antihemophilic Factor Drug Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Antihemophilic Factor Drug Product Location Distribution 3.4.2 Players Antihemophilic Factor Drug Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Antihemophilic Factor Drug by Geographic Region 4.1 World Historic Antihemophilic Factor Drug Market Size by Geographic Region (2017-2022) 4.1.1 Global Antihemophilic Factor Drug Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Antihemophilic Factor Drug Annual Revenue by Geographic Region 4.2 World Historic Antihemophilic Factor Drug Market Size by Country/Region (2017-2022) 4.2.1 Global Antihemophilic Factor Drug Annual Sales by Country/Region (2017-2022) 4.2.2 Global Antihemophilic Factor Drug Annual Revenue by Country/Region 4.3 Americas Antihemophilic Factor Drug Sales Growth 4.4 APAC Antihemophilic Factor Drug Sales Growth 4.5 Europe Antihemophilic Factor Drug Sales Growth 4.6 Middle East & Africa Antihemophilic Factor Drug Sales Growth 5 Americas 5.1 Americas Antihemophilic Factor Drug Sales by Country 5.1.1 Americas Antihemophilic Factor Drug Sales by Country (2017-2022) 5.1.2 Americas Antihemophilic Factor Drug Revenue by Country (2017-2022) 5.2 Americas Antihemophilic Factor Drug Sales by Type 5.3 Americas Antihemophilic Factor Drug Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Antihemophilic Factor Drug Sales by Region 6.1.1 APAC Antihemophilic Factor Drug Sales by Region (2017-2022) 6.1.2 APAC Antihemophilic Factor Drug Revenue by Region (2017-2022) 6.2 APAC Antihemophilic Factor Drug Sales by Type 6.3 APAC Antihemophilic Factor Drug Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Antihemophilic Factor Drug by Country 7.1.1 Europe Antihemophilic Factor Drug Sales by Country (2017-2022) 7.1.2 Europe Antihemophilic Factor Drug Revenue by Country (2017-2022) 7.2 Europe Antihemophilic Factor Drug Sales by Type 7.3 Europe Antihemophilic Factor Drug Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Antihemophilic Factor Drug by Country 8.1.1 Middle East & Africa Antihemophilic Factor Drug Sales by Country (2017-2022) 8.1.2 Middle East & Africa Antihemophilic Factor Drug Revenue by Country (2017-2022) 8.2 Middle East & Africa Antihemophilic Factor Drug Sales by Type 8.3 Middle East & Africa Antihemophilic Factor Drug Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Antihemophilic Factor Drug 10.3 Manufacturing Process Analysis of Antihemophilic Factor Drug 10.4 Industry Chain Structure of Antihemophilic Factor Drug 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Antihemophilic Factor Drug Distributors 11.3 Antihemophilic Factor Drug Customer 12 World Forecast Review for Antihemophilic Factor Drug by Geographic Region 12.1 Global Antihemophilic Factor Drug Market Size Forecast by Region 12.1.1 Global Antihemophilic Factor Drug Forecast by Region (2023-2028) 12.1.2 Global Antihemophilic Factor Drug Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Antihemophilic Factor Drug Forecast by Type 12.7 Global Antihemophilic Factor Drug Forecast by Application 13 Key Players Analysis 13.1 Bayer 13.1.1 Bayer Company Information 13.1.2 Bayer Antihemophilic Factor Drug Product Offered 13.1.3 Bayer Antihemophilic Factor Drug Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Bayer Main Business Overview 13.1.5 Bayer Latest Developments 13.2 Takeda 13.2.1 Takeda Company Information 13.2.2 Takeda Antihemophilic Factor Drug Product Offered 13.2.3 Takeda Antihemophilic Factor Drug Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Takeda Main Business Overview 13.2.5 Takeda Latest Developments 13.3 Novo Nordisk 13.3.1 Novo Nordisk Company Information 13.3.2 Novo Nordisk Antihemophilic Factor Drug Product Offered 13.3.3 Novo Nordisk Antihemophilic Factor Drug Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 Novo Nordisk Main Business Overview 13.3.5 Novo Nordisk Latest Developments 13.4 Pfizer 13.4.1 Pfizer Company Information 13.4.2 Pfizer Antihemophilic Factor Drug Product Offered 13.4.3 Pfizer Antihemophilic Factor Drug Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 Pfizer Main Business Overview 13.4.5 Pfizer Latest Developments 13.5 Grifols 13.5.1 Grifols Company Information 13.5.2 Grifols Antihemophilic Factor Drug Product Offered 13.5.3 Grifols Antihemophilic Factor Drug Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 Grifols Main Business Overview 13.5.5 Grifols Latest Developments 13.6 CSL Behring 13.6.1 CSL Behring Company Information 13.6.2 CSL Behring Antihemophilic Factor Drug Product Offered 13.6.3 CSL Behring Antihemophilic Factor Drug Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 CSL Behring Main Business Overview 13.6.5 CSL Behring Latest Developments 13.7 Sanofi 13.7.1 Sanofi Company Information 13.7.2 Sanofi Antihemophilic Factor Drug Product Offered 13.7.3 Sanofi Antihemophilic Factor Drug Sales, Revenue, Price and Gross Margin (2020-2022) 13.7.4 Sanofi Main Business Overview 13.7.5 Sanofi Latest Developments 13.8 Cigna 13.8.1 Cigna Company Information 13.8.2 Cigna Antihemophilic Factor Drug Product Offered 13.8.3 Cigna Antihemophilic Factor Drug Sales, Revenue, Price and Gross Margin (2020-2022) 13.8.4 Cigna Main Business Overview 13.8.5 Cigna Latest Developments 13.9 Octapharma 13.9.1 Octapharma Company Information 13.9.2 Octapharma Antihemophilic Factor Drug Product Offered 13.9.3 Octapharma Antihemophilic Factor Drug Sales, Revenue, Price and Gross Margin (2020-2022) 13.9.4 Octapharma Main Business Overview 13.9.5 Octapharma Latest Developments 13.10 GC Pharma 13.10.1 GC Pharma Company Information 13.10.2 GC Pharma Antihemophilic Factor Drug Product Offered 13.10.3 GC Pharma Antihemophilic Factor Drug Sales, Revenue, Price and Gross Margin (2020-2022) 13.10.4 GC Pharma Main Business Overview 13.10.5 GC Pharma Latest Developments 13.11 Hualan Biological Engineering 13.11.1 Hualan Biological Engineering Company Information 13.11.2 Hualan Biological Engineering Antihemophilic Factor Drug Product Offered 13.11.3 Hualan Biological Engineering Antihemophilic Factor Drug Sales, Revenue, Price and Gross Margin (2020-2022) 13.11.4 Hualan Biological Engineering Main Business Overview 13.11.5 Hualan Biological Engineering Latest Developments 13.12 Shanghai RAAS blood products 13.12.1 Shanghai RAAS blood products Company Information 13.12.2 Shanghai RAAS blood products Antihemophilic Factor Drug Product Offered 13.12.3 Shanghai RAAS blood products Antihemophilic Factor Drug Sales, Revenue, Price and Gross Margin (2020-2022) 13.12.4 Shanghai RAAS blood products Main Business Overview 13.12.5 Shanghai RAAS blood products Latest Developments 14 Research Findings and Conclusion

List of Tables Table 1. Antihemophilic Factor Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Antihemophilic Factor Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of 250 IU Table 4. Major Players of 500 IU Table 5. Major Players of 1000 IU Table 6. Major Players of 1500 IU Table 7. Major Players of 2000 IU Table 8. Major Players of 3000 IU Table 9. Major Players of 4000 IU Table 10. Major Players of Other potencies Table 11. Global Antihemophilic Factor Drug Sales by Type (2017-2022) & (K Units) Table 12. Global Antihemophilic Factor Drug Sales Market Share by Type (2017-2022) Table 13. Global Antihemophilic Factor Drug Revenue by Type (2017-2022) & ($ million) Table 14. Global Antihemophilic Factor Drug Revenue Market Share by Type (2017-2022) Table 15. Global Antihemophilic Factor Drug Sale Price by Type (2017-2022) & (USD/Unit) Table 16. Global Antihemophilic Factor Drug Sales by Application (2017-2022) & (K Units) Table 17. Global Antihemophilic Factor Drug Sales Market Share by Application (2017-2022) Table 18. Global Antihemophilic Factor Drug Revenue by Application (2017-2022) Table 19. Global Antihemophilic Factor Drug Revenue Market Share by Application (2017-2022) Table 20. Global Antihemophilic Factor Drug Sale Price by Application (2017-2022) & (USD/Unit) Table 21. Global Antihemophilic Factor Drug Sales by Company (2020-2022) & (K Units) Table 22. Global Antihemophilic Factor Drug Sales Market Share by Company (2020-2022) Table 23. Global Antihemophilic Factor Drug Revenue by Company (2020-2022) ($ Millions) Table 24. Global Antihemophilic Factor Drug Revenue Market Share by Company (2020-2022) Table 25. Global Antihemophilic Factor Drug Sale Price by Company (2020-2022) & (USD/Unit) Table 26. Key Manufacturers Antihemophilic Factor Drug Producing Area Distribution and Sales Area Table 27. Players Antihemophilic Factor Drug Products Offered Table 28. Antihemophilic Factor Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 29. New Products and Potential Entrants Table 30. Mergers & Acquisitions, Expansion Table 31. Global Antihemophilic Factor Drug Sales by Geographic Region (2017-2022) & (K Units) Table 32. Global Antihemophilic Factor Drug Sales Market Share Geographic Region (2017-2022) Table 33. Global Antihemophilic Factor Drug Revenue by Geographic Region (2017-2022) & ($ millions) Table 34. Global Antihemophilic Factor Drug Revenue Market Share by Geographic Region (2017-2022) Table 35. Global Antihemophilic Factor Drug Sales by Country/Region (2017-2022) & (K Units) Table 36. Global Antihemophilic Factor Drug Sales Market Share by Country/Region (2017-2022) Table 37. Global Antihemophilic Factor Drug Revenue by Country/Region (2017-2022) & ($ millions) Table 38. Global Antihemophilic Factor Drug Revenue Market Share by Country/Region (2017-2022) Table 39. Americas Antihemophilic Factor Drug Sales by Country (2017-2022) & (K Units) Table 40. Americas Antihemophilic Factor Drug Sales Market Share by Country (2017-2022) Table 41. Americas Antihemophilic Factor Drug Revenue by Country (2017-2022) & ($ Millions) Table 42. Americas Antihemophilic Factor Drug Revenue Market Share by Country (2017-2022) Table 43. Americas Antihemophilic Factor Drug Sales by Type (2017-2022) & (K Units) Table 44. Americas Antihemophilic Factor Drug Sales Market Share by Type (2017-2022) Table 45. Americas Antihemophilic Factor Drug Sales by Application (2017-2022) & (K Units) Table 46. Americas Antihemophilic Factor Drug Sales Market Share by Application (2017-2022) Table 47. APAC Antihemophilic Factor Drug Sales by Region (2017-2022) & (K Units) Table 48. APAC Antihemophilic Factor Drug Sales Market Share by Region (2017-2022) Table 49. APAC Antihemophilic Factor Drug Revenue by Region (2017-2022) & ($ Millions) Table 50. APAC Antihemophilic Factor Drug Revenue Market Share by Region (2017-2022) Table 51. APAC Antihemophilic Factor Drug Sales by Type (2017-2022) & (K Units) Table 52. APAC Antihemophilic Factor Drug Sales Market Share by Type (2017-2022) Table 53. APAC Antihemophilic Factor Drug Sales by Application (2017-2022) & (K Units) Table 54. APAC Antihemophilic Factor Drug Sales Market Share by Application (2017-2022) Table 55. Europe Antihemophilic Factor Drug Sales by Country (2017-2022) & (K Units) Table 56. Europe Antihemophilic Factor Drug Sales Market Share by Country (2017-2022) Table 57. Europe Antihemophilic Factor Drug Revenue by Country (2017-2022) & ($ Millions) Table 58. Europe Antihemophilic Factor Drug Revenue Market Share by Country (2017-2022) Table 59. Europe Antihemophilic Factor Drug Sales by Type (2017-2022) & (K Units) Table 60. Europe Antihemophilic Factor Drug Sales Market Share by Type (2017-2022) Table 61. Europe Antihemophilic Factor Drug Sales by Application (2017-2022) & (K Units) Table 62. Europe Antihemophilic Factor Drug Sales Market Share by Application (2017-2022) Table 63. Middle East & Africa Antihemophilic Factor Drug Sales by Country (2017-2022) & (K Units) Table 64. Middle East & Africa Antihemophilic Factor Drug Sales Market Share by Country (2017-2022) Table 65. Middle East & Africa Antihemophilic Factor Drug Revenue by Country (2017-2022) & ($ Millions) Table 66. Middle East & Africa Antihemophilic Factor Drug Revenue Market Share by Country (2017-2022) Table 67. Middle East & Africa Antihemophilic Factor Drug Sales by Type (2017-2022) & (K Units) Table 68. Middle East & Africa Antihemophilic Factor Drug Sales Market Share by Type (2017-2022) Table 69. Middle East & Africa Antihemophilic Factor Drug Sales by Application (2017-2022) & (K Units) Table 70. Middle East & Africa Antihemophilic Factor Drug Sales Market Share by Application (2017-2022) Table 71. Key Market Drivers & Growth Opportunities of Antihemophilic Factor Drug Table 72. Key Market Challenges & Risks of Antihemophilic Factor Drug Table 73. Key Industry Trends of Antihemophilic Factor Drug Table 74. Antihemophilic Factor Drug Raw Material Table 75. Key Suppliers of Raw Materials Table 76. Antihemophilic Factor Drug Distributors List Table 77. Antihemophilic Factor Drug Customer List Table 78. Global Antihemophilic Factor Drug Sales Forecast by Region (2023-2028) & (K Units) Table 79. Global Antihemophilic Factor Drug Sales Market Forecast by Region Table 80. Global Antihemophilic Factor Drug Revenue Forecast by Region (2023-2028) & ($ millions) Table 81. Global Antihemophilic Factor Drug Revenue Market Share Forecast by Region (2023-2028) Table 82. Americas Antihemophilic Factor Drug Sales Forecast by Country (2023-2028) & (K Units) Table 83. Americas Antihemophilic Factor Drug Revenue Forecast by Country (2023-2028) & ($ millions) Table 84. APAC Antihemophilic Factor Drug Sales Forecast by Region (2023-2028) & (K Units) Table 85. APAC Antihemophilic Factor Drug Revenue Forecast by Region (2023-2028) & ($ millions) Table 86. Europe Antihemophilic Factor Drug Sales Forecast by Country (2023-2028) & (K Units) Table 87. Europe Antihemophilic Factor Drug Revenue Forecast by Country (2023-2028) & ($ millions) Table 88. Middle East & Africa Antihemophilic Factor Drug Sales Forecast by Country (2023-2028) & (K Units) Table 89. Middle East & Africa Antihemophilic Factor Drug Revenue Forecast by Country (2023-2028) & ($ millions) Table 90. Global Antihemophilic Factor Drug Sales Forecast by Type (2023-2028) & (K Units) Table 91. Global Antihemophilic Factor Drug Sales Market Share Forecast by Type (2023-2028) Table 92. Global Antihemophilic Factor Drug Revenue Forecast by Type (2023-2028) & ($ Millions) Table 93. Global Antihemophilic Factor Drug Revenue Market Share Forecast by Type (2023-2028) Table 94. Global Antihemophilic Factor Drug Sales Forecast by Application (2023-2028) & (K Units) Table 95. Global Antihemophilic Factor Drug Sales Market Share Forecast by Application (2023-2028) Table 96. Global Antihemophilic Factor Drug Revenue Forecast by Application (2023-2028) & ($ Millions) Table 97. Global Antihemophilic Factor Drug Revenue Market Share Forecast by Application (2023-2028) Table 98. Bayer Basic Information, Antihemophilic Factor Drug Manufacturing Base, Sales Area and Its Competitors Table 99. Bayer Antihemophilic Factor Drug Product Offered Table 100. Bayer Antihemophilic Factor Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 101. Bayer Main Business Table 102. Bayer Latest Developments Table 103. Takeda Basic Information, Antihemophilic Factor Drug Manufacturing Base, Sales Area and Its Competitors Table 104. Takeda Antihemophilic Factor Drug Product Offered Table 105. Takeda Antihemophilic Factor Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 106. Takeda Main Business Table 107. Takeda Latest Developments Table 108. Novo Nordisk Basic Information, Antihemophilic Factor Drug Manufacturing Base, Sales Area and Its Competitors Table 109. Novo Nordisk Antihemophilic Factor Drug Product Offered Table 110. Novo Nordisk Antihemophilic Factor Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 111. Novo Nordisk Main Business Table 112. Novo Nordisk Latest Developments Table 113. Pfizer Basic Information, Antihemophilic Factor Drug Manufacturing Base, Sales Area and Its Competitors Table 114. Pfizer Antihemophilic Factor Drug Product Offered Table 115. Pfizer Antihemophilic Factor Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 116. Pfizer Main Business Table 117. Pfizer Latest Developments Table 118. Grifols Basic Information, Antihemophilic Factor Drug Manufacturing Base, Sales Area and Its Competitors Table 119. Grifols Antihemophilic Factor Drug Product Offered Table 120. Grifols Antihemophilic Factor Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 121. Grifols Main Business Table 122. Grifols Latest Developments Table 123. CSL Behring Basic Information, Antihemophilic Factor Drug Manufacturing Base, Sales Area and Its Competitors Table 124. CSL Behring Antihemophilic Factor Drug Product Offered Table 125. CSL Behring Antihemophilic Factor Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 126. CSL Behring Main Business Table 127. CSL Behring Latest Developments Table 128. Sanofi Basic Information, Antihemophilic Factor Drug Manufacturing Base, Sales Area and Its Competitors Table 129. Sanofi Antihemophilic Factor Drug Product Offered Table 130. Sanofi Antihemophilic Factor Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 131. Sanofi Main Business Table 132. Sanofi Latest Developments Table 133. Cigna Basic Information, Antihemophilic Factor Drug Manufacturing Base, Sales Area and Its Competitors Table 134. Cigna Antihemophilic Factor Drug Product Offered Table 135. Cigna Antihemophilic Factor Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 136. Cigna Main Business Table 137. Cigna Latest Developments Table 138. Octapharma Basic Information, Antihemophilic Factor Drug Manufacturing Base, Sales Area and Its Competitors Table 139. Octapharma Antihemophilic Factor Drug Product Offered Table 140. Octapharma Antihemophilic Factor Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 141. Octapharma Main Business Table 142. Octapharma Latest Developments Table 143. GC Pharma Basic Information, Antihemophilic Factor Drug Manufacturing Base, Sales Area and Its Competitors Table 144. GC Pharma Antihemophilic Factor Drug Product Offered Table 145. GC Pharma Antihemophilic Factor Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 146. GC Pharma Main Business Table 147. GC Pharma Latest Developments Table 148. Hualan Biological Engineering Basic Information, Antihemophilic Factor Drug Manufacturing Base, Sales Area and Its Competitors Table 149. Hualan Biological Engineering Antihemophilic Factor Drug Product Offered Table 150. Hualan Biological Engineering Antihemophilic Factor Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 151. Hualan Biological Engineering Main Business Table 152. Hualan Biological Engineering Latest Developments Table 153. Shanghai RAAS blood products Basic Information, Antihemophilic Factor Drug Manufacturing Base, Sales Area and Its Competitors Table 154. Shanghai RAAS blood products Antihemophilic Factor Drug Product Offered Table 155. Shanghai RAAS blood products Antihemophilic Factor Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 156. Shanghai RAAS blood products Main Business Table 157. Shanghai RAAS blood products Latest Developments List of Figures Figure 1. Picture of Antihemophilic Factor Drug Figure 2. Antihemophilic Factor Drug Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Antihemophilic Factor Drug Sales Growth Rate 2017-2028 (K Units) Figure 7. Global Antihemophilic Factor Drug Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Antihemophilic Factor Drug Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of 250 IU Figure 10. Product Picture of 500 IU Figure 11. Product Picture of 1000 IU Figure 12. Product Picture of 1500 IU Figure 13. Product Picture of 2000 IU Figure 14. Product Picture of 3000 IU Figure 15. Product Picture of 4000 IU Figure 16. Product Picture of Other potencies Figure 17. Global Antihemophilic Factor Drug Sales Market Share by Type in 2021 Figure 18. Global Antihemophilic Factor Drug Revenue Market Share by Type (2017-2022) Figure 19. Antihemophilic Factor Drug Consumed in Adult Figure 20. Global Antihemophilic Factor Drug Market: Adult (2017-2022) & (K Units) Figure 21. Antihemophilic Factor Drug Consumed in Pediatric Figure 22. Global Antihemophilic Factor Drug Market: Pediatric (2017-2022) & (K Units) Figure 23. Global Antihemophilic Factor Drug Sales Market Share by Application (2017-2022) Figure 24. Global Antihemophilic Factor Drug Revenue Market Share by Application in 2021 Figure 25. Antihemophilic Factor Drug Revenue Market by Company in 2021 ($ Million) Figure 26. Global Antihemophilic Factor Drug Revenue Market Share by Company in 2021 Figure 27. Global Antihemophilic Factor Drug Sales Market Share by Geographic Region (2017-2022) Figure 28. Global Antihemophilic Factor Drug Revenue Market Share by Geographic Region in 2021 Figure 29. Global Antihemophilic Factor Drug Sales Market Share by Region (2017-2022) Figure 30. Global Antihemophilic Factor Drug Revenue Market Share by Country/Region in 2021 Figure 31. Americas Antihemophilic Factor Drug Sales 2017-2022 (K Units) Figure 32. Americas Antihemophilic Factor Drug Revenue 2017-2022 ($ Millions) Figure 33. APAC Antihemophilic Factor Drug Sales 2017-2022 (K Units) Figure 34. APAC Antihemophilic Factor Drug Revenue 2017-2022 ($ Millions) Figure 35. Europe Antihemophilic Factor Drug Sales 2017-2022 (K Units) Figure 36. Europe Antihemophilic Factor Drug Revenue 2017-2022 ($ Millions) Figure 37. Middle East & Africa Antihemophilic Factor Drug Sales 2017-2022 (K Units) Figure 38. Middle East & Africa Antihemophilic Factor Drug Revenue 2017-2022 ($ Millions) Figure 39. Americas Antihemophilic Factor Drug Sales Market Share by Country in 2021 Figure 40. Americas Antihemophilic Factor Drug Revenue Market Share by Country in 2021 Figure 41. United States Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 42. Canada Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 43. Mexico Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 44. Brazil Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 45. APAC Antihemophilic Factor Drug Sales Market Share by Region in 2021 Figure 46. APAC Antihemophilic Factor Drug Revenue Market Share by Regions in 2021 Figure 47. China Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 48. Japan Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 49. South Korea Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 50. Southeast Asia Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 51. India Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 52. Australia Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 53. Europe Antihemophilic Factor Drug Sales Market Share by Country in 2021 Figure 54. Europe Antihemophilic Factor Drug Revenue Market Share by Country in 2021 Figure 55. Germany Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 56. France Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 57. UK Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 58. Italy Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 59. Russia Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 60. Middle East & Africa Antihemophilic Factor Drug Sales Market Share by Country in 2021 Figure 61. Middle East & Africa Antihemophilic Factor Drug Revenue Market Share by Country in 2021 Figure 62. Egypt Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 63. South Africa Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 64. Israel Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 65. Turkey Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 66. GCC Country Antihemophilic Factor Drug Revenue Growth 2017-2022 ($ Millions) Figure 67. Manufacturing Cost Structure Analysis of Antihemophilic Factor Drug in 2021 Figure 68. Manufacturing Process Analysis of Antihemophilic Factor Drug Figure 69. Industry Chain Structure of Antihemophilic Factor Drug Figure 70. Channels of Distribution Figure 71. Distributors Profiles